Tumor response to etoposide plus cisplatin occurred in 5 of 7 patients with Ki67 > 60% and 7 of 24 with Ki67 ≤ 60%, which was significantly different (RR; 71.4% vs. 29.2%, P = 0.043). The gene discussed is MKI67; the disease is neoplasm.